SCHEMBL238964

SCHEMBL238964

COC(=O)C(C)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275280 0.82 SMN1; SMN2 (0.52)
SCHEMBL10805452 0.79 SMN1; SMN2 (0.50)
SCHEMBL26658220 0.79 SMN1; SMN2 (0.50)
SCHEMBL23956399 0.77 SMN1; SMN2 (0.39)
Ammonia Solution, Strong SCHEMBL8809999 0.77 SMN1; SMN2 (0.48)
SCHEMBL1920162 0.77 SMN1; SMN2 (0.48)
SCHEMBL10559145 0.76 SMN1; SMN2 (0.42)
SCHEMBL5632475 0.76 SMN1; SMN2 (0.42)
SCHEMBL16847431 0.75 SMN1; SMN2 (0.38)
SCHEMBL334917 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-9110740-A None JP disclosed
US-8383813-B2 Fused pyrrolocarbazoles CEPHALON, INC. (US) 2013-02-26 US disclosed
US-20120004253-A1 Novel Fused Pyrrolocarbazoles CEPHALON, INC. (US) 2012-01-05 US disclosed
US-8044064-B2 Fused pyrrolocarbazoles CEPHALON, INC. (US) 2011-10-25 US disclosed
EP-1704148-B1 NOVEL FUSED PYRROLOCARBAZOLES CEPHALON INC (US) 2011-03-02 EP disclosed
US-20100152208-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. 2010-06-17 US disclosed
US-20100152196-A1 Novel Fused Pyrrolocarbazoles CEPHALON, INC. (US) 2010-06-17 US disclosed
US-7671064-B2 Fused pyrrolocarbazoles CEPHALON, INC. (US) 2010-03-02 US disclosed
EP-2152719-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2010-02-17 EP disclosed
WO-2008141455-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2008-11-27 WO disclosed
CN-86101066-A Process for producing novel trifluoromethyl ketone substituted peptide derivatives 1986-11-05 CN disclosed
EP-0130109-A2 Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure MERCK & CO. INC. (US) 1985-01-02 EP disclosed
US-4477466-A Acyloxy derivatives of [phenylsulfonyl(or sulfinyl)]thiophenesulfonamide for the topical treatment of elevated intraocular pressure MERCK & CO., INC. (US) 1984-10-16 US disclosed
US-4429146-A PRE- AND POSTEMERGENCE GAF CORPORATION (US) 1984-01-31 US disclosed
EP-0066106-A1 New phenoxybenzoates, process for preparing these compounds, compositions containing them and method of use GAF CORPORATION (US) 1982-12-08 EP disclosed
US-4329473-A HYPOTENSIVE AGENTS SRI INTERNATIONAL 1982-05-11 US disclosed
EP-0043858-A1 HETERO RING-SUBSTITUTED OXOALKANOIC ACID DERIVATIVES Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1982-01-20 EP disclosed
EP-0001688-B1 DERIVATIVES OF C-076 COMPOUNDS AND THEIR PREPARATION MERCK & CO. INC. (US) 1981-11-04 EP disclosed
US-4201861-A Acyl derivatives of C-076 compounds MERCK & CO., INC. (US) 1980-05-06 US disclosed
EP-0001688-A1 Derivatives of C-076 compounds and their preparation MERCK & CO. INC. (US) 1979-05-02 EP disclosed